Stay updated on Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page.

Latest updates to the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision label v3.5.4 was added and the previous label v3.5.3 was removed, reflecting an update to the page's version metadata. This change does not alter the substantive content or functionality of the page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows an updated ClinicalTrials.gov site revision/version number (v3.5.3 rather than v3.5.2).SummaryDifference0.0%

- Check38 days agoChange DetectedRevision updated to v3.5.2.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision labels updated from v3.4.3 to v3.5.0. No study content or data appear to be affected.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision notice updated to v3.4.3. The previous revision v3.4.2 is no longer displayed.SummaryDifference0.0%

- Check102 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, indicating a minor version update in the study documents. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page.